Announcement

The Board of Directors of the NanoMedicines Innovation Network (NMIN), a national Networks of Centres of Excellence (NCE) funded by the Government of Canada, has appointed Dr. Gilbert Walker Scientific Director & CEO, effective 14 September 2022. Dr. Walker is a Distinguished Professor in the Department of Chemistry in the… Read More »NMIN Board of Directors names Dr. Gilbert Walker Scientific Director & CEO

https://youtu.be/4eg6Y8x1JXE?list=PLh7NyssbO61nky9vVCrRsJG9izYAl5VV6Video profile of GGIA Laureate Acuitas A research team assembled in UBC approximately 40 years ago by NMIN’s Founding Scientific Director, Dr. Pieter Cullis, is receiving a 2022 Governor General’s Innovation Award for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable… Read More »NMIN’s Founding Scientific Director receives Governor General’s Innovation Award

NMIN spin-off company NanoVation Therapeutics™ (NTx) is growing rapidly and is expanding its overseas operations with the launch of its first NanoVation GENErator™ in the UK, based at the Harwell Science and Innovation Campus near Oxford. The Honourable François-Philippe Champagne PC, MP (Minister of Innovation, Science and Industry) visits NanoVation’s… Read More »NMIN spin-off company NanoVation Therapeutics is expanding into UK

Canadian nanomedicine scientist and NMIN founder Dr. Pieter Cullis, together with his Germany and US-based peers Drs Katalin Kariko and Drew Weissman, have been honoured with a 2022 Canada Gairdner International Award for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines. Dr. Cullis and colleagues at the… Read More »NMIN’s Founding Scientific Director wins 2022 Canada Gairdner International Award

Canadian nanomedicine scientist and NMIN founder Dr. Pieter Cullis, together with his Germany and US-based peers Drs Katalin Kariko and Drew Weissman, have been honoured with the inaugural VinFuture Grand Prize for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines. Dr. Cullis and colleagues at the University… Read More »NMIN’s Founding Scientific Director wins VinFuture Foundation’s first global sci-tech award

Entos Pharmaceuticals Inc., led by NMIN researcher Dr. John Lewis, has received the 2020 BioAlberta Achievement award for Company of the Year. At its 16 November 2021 AGM, BioAlberta announced the recipients of its 2020 Achievement Awards, recognizing individuals and companies who have contributed to the success of Alberta’s life… Read More »Company led by NMIN’s Dr. John Lewis named BioAlberta’s Company of the Year 2020

Canadian scientist Dr. Pieter Cullis, together with his peers Drs Katalin Kariko and Drew Weissman, have been honoured with the 2021 Prince Mahidol Award for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines. Through over 40 years of work in his University of British Columbia (UBC) laboratory,… Read More »Canadian scientist awarded international prize for COVID vaccine technology

https://youtu.be/AuEkO4Ge-q4 Thomas Madden (Acuitas) interviewed on Global TV Acuitas Therapeutics, the Vancouver, BC-based biotech company co-founded by NMIN research leader Dr. Pieter Cullis, has been granted a Global Impact Award by Life Sciences British Columbia, in recognition of the company’s “extraordinary leadership and efforts they made in the development of… Read More »Acuitas Therapeutics wins Global Impact Award for LNPs in COVID vaccines

“There is no time like the present to try to achieve impossible dreams” The contributions of NMIN Research Leader Dr. Pieter Cullis toward enabling effective mRNA vaccines, most notably against COVID-19, continue to garner high-profile recognition. Most recently, Dr. Cullis was featured on CBC’s Quirks & Quarks; his role was… Read More »LNPs & mRNA vaccines: Dr. Pieter Cullis in Nature Reviews Materials